10x Genomics, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year One
10x Genomics, Inc. (TXG) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $9.64 million as of 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Notes › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-02-13
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $9.64M.
- 2024-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.86M.
- 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.86M.
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $2.51M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2025-12-31 | $9.64M 10-K · filed 2026-02-13 |
| 2024-12-31 | $1.86M 10-K · filed 2025-02-13 |
| 2023-12-31 | $1.86M 10-K · filed 2024-02-15 |
| 2022-12-31 | $2.51M 10-K · filed 2023-02-16 |
| 2021-12-31 | $2.54M 10-K · filed 2022-02-18 |
| 2021-09-30 | $2.54M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $2.54M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $2.54M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $2.00M 10-K · filed 2021-02-26 |
| 2020-09-30 | $1.81M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.63M 10-Q · filed 2020-08-12 |
| 2019-12-31 | $1.63M 10-K · filed 2020-02-27 |